How to Buy Nurix Therapeutics Stock

Nurix Therapeutics Inc

Nurix Therapeutics, Inc. , a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Nurix Therapeutics stock last closed at $26.80, down 1.18% from the previous day, and has increased 109.7% in one year. It has overperformed other stocks in the Biotechnology industry by 1.76 percentage points. Nurix Therapeutics stock is currently +129.65% from its 52-week low of $11.67, and -5.07% from its 52-week high of $28.23.

As of Oct 30, 2026, there are 109.25M shares of NRIX outstanding. The market cap of NRIX is $2.93B. In the last 24 hours, 2.31M NRIX shares were traded.

How to Buy Nurix Therapeutics Stock

Wondering how to invest in Nurix Therapeutics stock? Here's how.

  1. Decide where to buy Nurix Therapeutics stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you decide where to buy Nurix Therapeutics stock.
  2. Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Deposit funds into your investment account: Select your method of payment and add your information.
  4. Research Nurix Therapeutics stock: The Nurix Therapeutics ticker symbol is NRIX. Is Nurix Therapeutics stock a good investment? Should you buy shares of NRIX? How do NRIX's underlying business fundamentals look? Do top analysts think Nurix Therapeutics is a good buy? Why has NRIX's stock price moved recently? (Hint: Our stock market research tools can help you decide if NRIX is a good stock to buy).
  5. Place your NRIX purchase: Decide if you will purchase NRIX shares at the current market price or use a limit order to purchase NRIX stock at a specific price.
  6. Get updates on your investment in NRIX: Create a watchlist to get the latest news on your position in Nurix Therapeutics stock.

Step 1: Decide where to buy Nurix Therapeutics stock

You will need an online brokerage account in order to access the NASDAQ market and buy NRIX stock.

A brokerage account enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

In our opinion, eToro is the best stock brokerage. Here's why:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to world markets: From Tech to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've selected the best brokerage, it's time to fill out some personal info so you can buy NRIX stock today.

How to Open a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal info to create your new trading account.
  1. Submit your application by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you've filled out your info on the best stock investing app, your next step is to transfer the money for your investment:

Check out the walkthrough below for more details depositing money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Nurix Therapeutics stock

After you have decided on the best place to buy Nurix Therapeutics stock, it's absolutely critical to evaluate their stock prior to investing, so you truly wrap your head around the risk as well as the opportunity.

Nurix Therapeutics Metrics

NRIX Price
$26.80
1w %
5.76%
1y %
109.7%
5y %
-22.32%
P/E
10.72x
P/B
3.02x
P/S
4.26x
PEG
N/A
Revenue
$701.94M
Earnings
$294.88M
Fore. Rev. Growth
-43.38%
Fore. Earn. Growth
N/A
Market Cap
$2.93B
Next Earnings
N/A
Next Dividend
N/A

NRIX Due Diligence Checks

WallStreetZen was built to help part-time investors perform more accurate fundamental analysis.

You can view all of the due diligence checks on NRIX's stock page.

What is the fair value of NRIX stock?

You can use a variety of different financial metrics, analyses, models, and charts to gauge NRIX's true value.

Using relative valuations methods:

  • NRIX could be undervalued based on its P/E ratio of 10.72x, relative to Biotechnology industry P/E ratio of 16.38x
  • NRIX may be undervalued based on its P/B ratio of 3.02x, relative to Biotechnology industry P/B ratio of 5.17x

You can do additional valuation analysis on NRIX's stock here.

NRIX Financials at a glance

Positive Health Checks:

  • There are more short-term assets than short-term liabilities on the NRIX balance sheet.
  • NRIX earnings of $308.21M is not sufficient to cover its interest payments.
  • Total NRIX debt is lower than 5 years ago, relative to shareholder equity.
  • NRIX has a low debt to equity ratio of 0.23.
  • There are more short-term assets than long-term liabilities on the NRIX balance sheet.
  • NRIX's operating cash flow of $379.31M allows it to safely service it's debt of $65.33M.
  • NRIX profit margin has gone up from -292.5% to 42% in the past year.

Do Wall Street analysts think it's a good time to buy Nurix Therapeutics stock

Out of 13 Wall Street analysts who give forecasts on NRIX, the consensus analyst rating on Nurix Therapeutics is a Strong Buy

Please note that analyst ratings are not stock recommendations, nor are they financial advice.

Latest NRIX Analyst Forecasts

Gil Blum, a top 3% analyst from Needham reiterates NRIX with a buy rating and maintains their NRIX price target from $34.00 to $34.00, on Oct 13, 2026.

Terence Flynn, a top 4% analyst from Morgan Stanley maintains NRIX with a strong buy rating and raises their NRIX price target from $36.00 to $38.00, on Jul 28, 2026.

Morgan Stanley's Terence Flynn raised their price target on Nurix Therapeutics (NASDAQ: NRIX) by 5.6% from $36 to $38 on 2026/07/28. The analyst maintained their Strong Buy rating on the stock.

Flynn said their price target hike on Nurix Therapeutics was catalyzed by benefits from  recently-closed Roche* collaboration.

Footnotes

* Roche trades under the ticker, RHHBY, on the over-the-counter market through the OTCQX International Premier tier in theU.S. Its primary underlying shares and participation certificates trade on the SIX Swiss Exchange under the symbols RO and ROP.

David Dai, a bottom 7% analyst from UBS maintains NRIX with a strong buy rating and raises their NRIX price target from $23.00 to $31.00, on Jul 22, 2026.

Joseph Catanzaro, a top 18% analyst from Mizuho maintains NRIX with a buy rating and raises their NRIX price target from $30.00 to $34.00, on Jul 13, 2026.

Stephen Willey, a top 22% analyst from Stifel Nicolaus maintains NRIX with a strong buy rating and raises their NRIX price target from $34.00 to $40.00, on Jul 10, 2026.

You can dig deeper into what analysts are projecting on the Nurix Therapeutics stock forecast page.

NRIX Trading Indicators

SMA10
26.13
SMA20
24.57
SMA50
24.98
SMA100
24.02
SMA200
20.18
MACD
0.72
MACD Signal
0.37
MACD Histogram
0.35
RSI
63.81
Stochastic %K
89.47
Stochastic %D
91.9
StochRSI %K
94.59
StochRSI %D
95.97

How are NRIX Revenues/Earnings doing?

Last year, NRIX revenue was $701.94M. During the last 5 year, NRIX's revenue has increased by 89.08% per year. This was faster than the Biotechnology industry average of 30.09%.

Learn more about NRIX's earnings and revenue performance here.

Are NRIX executives and large shareholders buying or selling the stock?

Over the past year, insiders at NRIX have sold more shares than they have bought.

Gwenn Hansen, CSci of NRIX, was the latest NRIX insider to buy. They bought $2,700.72 worth of NRIX shares on Oct 15, 2026.

Get more info about who owns NRIX stock here.

Does NRIX provide a stable income stream?

No, Nurix Therapeutics doesn't provide an income stream by paying out dividends.

What do other traders have to say about NRIX?

One of the reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Place your NRIX purchase

There are two primary types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at a given dollar amount, use a limit order.

Hit the Open button and eToro will place your order.

If you require additional assistance investing in stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Get updates on your investment in NRIX

Now that you own some shares in NRIX, you'll want to keep up with your new investment.

Start a watchlist to see the latest developments about your NRIX stock.

NRIX Feed

How to Buy Stock in Nurix Therapeutics

To summarize, here are the 6 steps for buying Nurix Therapeutics stock:

  1. Decide where to buy Nurix Therapeutics stock
  2. Create a brokerage account
  3. Deposit funds into your investment account
  4. Research Nurix Therapeutics stock
  5. Place your NRIX purchase
  6. Get updates on your investment in NRIX

If you need a online brokerage, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep an eye on your investment in Nurix Therapeutics, add NRIX to your watchlist below.

NASDAQ: NRIX
$26.80-0.32 (-1.18%)
Updated Oct 30, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: NRIX
$26.80-0.32 (-1.18%)
Updated Oct 30, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Nurix Therapeutics share?

As of Oct 30, 2026, it costs $26.80 to buy one share of Nurix Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.373 shares of NRIX.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Nurix Therapeutics stock?

According to 13 Wall Street analysts who monitor Nurix Therapeutics, their consensus recommendation is to buy Nurix Therapeutics stock.

What is the best way to buy Nurix Therapeutics stock?

One way to place an order for Nurix Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.